- CEO
- Kyung-Nam Kim
- Full Time Employees
- 86
- Sector
- Health technology
- Industry
- Medical specialties
- Address
- Seongnam-si South Korea
- IPO Date
- Jun 5, 2019
- Business
- Micro Digital Co., Ltd. is a South Korea-based biomedical engineering and life sciences equipment company specializing in the development, manufacture, and distribution of bioprocess systems, automated diagnostic platforms, and precision analytical laboratory instrumentation. Founded in 2002 and headquartered in Seongnam-si, Gyeonggi-do, South Korea, the company serves biopharmaceutical manufacturers, contract development and manufacturing organizations (CDMOs), academic and clinical research institutes, and cellular agriculture enterprises across the Asia-Pacific, North American, and European markets. Micro Digital Co., Ltd. organizes its commercial operations into three primary business divisions: Bioprocess Systems, Biomedical Laboratory Instruments, and In Vitro Diagnostic Solutions. The Bioprocess Systems segment manufactures the proprietary CELBIC series of single-use bioreactors featuring orbital rocking mixing mechanisms for low-shear, high-density cell culture across scalable volumes ranging from 5 liters to 1,000 liters (including the CELBIC 5, CELBIC 100, CELBIC 200, CELBIC 500, and CELBIC 1000 models); single-use bioprocessing consumables, encompassing three-dimensional disposable culture bags, two-dimensional liquid storage and transfer bags, tube manifolds, and aseptic sampling systems; and bioprocess engineering consulting services. The Biomedical Laboratory Instruments segment develops optical analytical devices, comprising the Nabi micro-volume ultraviolet-visible (UV/Vis) nano spectrophotometer; the Mobi microplate spectrophotometer; the Ubi series spectrophotometric instruments (Ubi-490, Ubi-600, and Ubi-800); the Lumi single-tube and Lubi Plus microplate luminescence readers; and the iSBS automated sample banking and liquid handling system. The In Vitro Diagnostic Solutions segment supplies the DxBIC automated immunoassay system for high-throughput clinical sample processing; diagnostic cartridge consumables; and integrated laboratory automation robotics. In recent strategic developments, Micro Digital Co., Ltd. expanded its global commercialization reach by entering into a supply and distribution partnership with U.S.-based motion and control leader Parker Hannifin, introducing its single-use bioreactor technology into the North American biomanufacturing market under Parker Hannifin's OrbTec brand. The company has also broadened its industrial application scope through bioprocess development agreements with cultivated meat technology developers, including SeaWith, to optimize large-scale cell biomass production using CELBIC systems. Furthermore, Micro Digital Co., Ltd. has initiated strategic research and development initiatives focused on artificial intelligence-enabled bioprocessing platforms and cloud-connected automation, while managing corporate governance adjustments and listing compliance procedures on the KOSDAQ market.